Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02601378
Title A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | ESP | AUS

Facility Status City State Zip Country Details
Columbia University Medical Center New York New York 10032 United States Details
Novartis Investigative Site Westmead New South Wales 2145 Australia Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Leiden 2300 RC Netherlands Details
Novartis Investigative Site Oslo 0379 Norway Details
Novartis Investigative Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field